Trelegy – based on corticosteroid fluticasone furoate, LAMA umeclidinium and LABA vilanterol and approved in 2017 – is central to GSK’s efforts to replace its COPD blockbuster Seretide ...
Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...
The company ranked 6th in Business Today - Stern Stewart & Co. listing of Indias best Wealth Creator Companies and also the launched Seretide for Asthma. The merger of SmithKline Beecham ...
What does Nifty Smallcap 250 represent? Nifty SmallCap 250 focuses on smaller companies' performance, comprising 250 small-cap stocks listed on the National Stock Exchange (NSE), providing investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback